Correlation of Erythrocyte Sedimentation Rate and C-Reactive Protein With Pediatric Inflammatory Bowel Disease

Arik Alper1, Lucy Zhang, Dinesh S Pashankar

  • 1Department of Pediatrics, Yale University, New Haven, CT.

Insights

Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) showed limited utility in predicting inflammatory bowel disease (IBD) activity in children. Normal values were common at diagnosis, and correlations varied, particularly for Crohn disease.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Chemistry
  • Inflammatory Bowel Disease Research

Background:

  • Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are commonly used inflammatory markers.
  • Their utility in assessing disease activity in pediatric inflammatory bowel disease (IBD) requires further clarification.

Purpose of the Study:

  • To investigate the correlation of ESR and CRP with IBD diagnosis.
  • To assess the relationship between ESR and CRP and disease activity (clinical, endoscopic, histological, radiographic) during a 5-year follow-up in children with IBD.

Main Methods:

  • Retrospective chart review of 135 children diagnosed with IBD.
  • Correlation analysis of ESR and CRP values with various disease activity parameters over 5 years.
  • Evaluation of diagnostic and follow-up data for Crohn disease and ulcerative colitis.

Main Results:

  • Normal ESR and CRP levels were observed in a significant proportion of children at diagnosis (up to 28% for Crohn disease, 42% for ulcerative colitis).
  • ESR and CRP correlation with Crohn disease activity depended on initial values and analysis method.
  • ESR and CRP were not effective in predicting ulcerative colitis activity or radiographic small bowel Crohn disease during follow-up.

Conclusions:

  • ESR and CRP have limited value in diagnosing and monitoring pediatric IBD, especially ulcerative colitis.
  • The predictive value of ESR and CRP for Crohn disease activity is inconsistent and depends on baseline levels.
  • Alternative biomarkers may be needed for accurate assessment of IBD activity in children.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
998
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
871
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
684
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
893